Optimal Antithrombotic Treatment of Patients with Atrial Fibrillation Early after an Acute Coronary Syndrome—Triple Therapy, Dual Antithrombotic Therapy with an Anticoagulant… Or,...

por Limbruno, Ugo, De Sensi, Francesco, Cresti, Alberto, Picchi, Andrea, Lena, Fabio, De Caterina, Raffaele
Publicado 2020

Insulin Glargine U100 Utilization in Patients with Type 2 Diabetes in an Italian Real-World Setting: A Retrospective Study

por Degli Esposti, Luca, Perrone, Valentina, Saragoni, Stefania, Blini, Valerio, Buda, Stefano, D'avella, Rosella, Gasperini, Gina, Lena, Fabio, Fanelli, Francesca, Gazzi, Luca, Giorgino, Francesco
Publicado 2019

The Epidemiology, Treatment Patterns and Economic Burden of Different Phenotypes of Multiple Sclerosis in Italy: Relapsing-Remitting Multiple Sclerosis and Secondary Progressive Mu...

por Perrone, Valentina, Veronesi, Chiara, Giacomini, Elisa, Citraro, Rita, Dell’Orco, Stefania, Lena, Fabio, Paciello, Arrigo, Resta, Anna Maria, Nica, Mihaela, Ritrovato, Daniela, Degli Esposti, Luca
Publicado 2022

Longitudinal assessment of systemic steroid therapy on hyperinflammatory endothelial biomarker profiles and serology responses of COVID-19 patients

por Sims, Jonathan T., Chang, Ching-Yun, Poorbaugh, Josh, Daniels, Montanea, Beasley, Stephanie L., Zhang, Lin, Rodgers, George H., Lena, Fabio, Lacerenza, Leonardo G., Sposato, Bruno, Dupont, Annabelle, Susen, Sophie, Casalini, Giacomo, Corbellino, Mario, Stebbing, Justin, Krishnan, Venkatesh
Publicado 2022

Real-World Analysis of Outcomes and Economic Burden in Patients with Chronic Kidney Disease with and without Secondary Hyperparathyroidism among a Sample of the Italian Population

por Barbuto, Simona, Perrone, Valentina, Veronesi, Chiara, Dovizio, Melania, Zappulo, Fulvia, Vetrano, Daniele, Giannini, Sandro, Fusaro, Maria, Ancona, Domenica Daniela, Barbieri, Antonietta, Ferrante, Fulvio, Lena, Fabio, Palcic, Stefano, Re, Davide, Rizzi, Francesca Vittoria, Cogliati, Paolo, Soro, Marco, Esposti, Luca Degli, Cianciolo, Giuseppe
Publicado 2023

JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortality

por Stebbing, Justin, Sánchez Nievas, Ginés, Falcone, Marco, Youhanna, Sonia, Richardson, Peter, Ottaviani, Silvia, Shen, Joanne X., Sommerauer, Christian, Tiseo, Giusy, Ghiadoni, Lorenzo, Virdis, Agostino, Monzani, Fabio, Rizos, Luis Romero, Forfori, Francesco, Avendaño Céspedes, Almudena, De Marco, Salvatore, Carrozzi, Laura, Lena, Fabio, Sánchez-Jurado, Pedro Manuel, Lacerenza, Leonardo Gianluca, Cesira, Nencioni, Caldevilla Bernardo, David, Perrella, Antonio, Niccoli, Laura, Méndez, Lourdes Sáez, Matarrese, Daniela, Goletti, Delia, Tan, Yee-Joo, Monteil, Vanessa, Dranitsaris, George, Cantini, Fabrizio, Farcomeni, Alessio, Dutta, Shuchismita, Burley, Stephen K., Zhang, Haibo, Pistello, Mauro, Li, William, Romero, Marta Mas, Andrés Pretel, Fernando, Simón-Talero, Rafaela Sánchez, García-Molina, Rafael, Kutter, Claudia, Felce, James H., Nizami, Zehra F., Miklosi, Andras G., Penninger, Josef M., Menichetti, Francesco, Mirazimi, Ali, Abizanda, Pedro, Lauschke, Volker M.
Publicado 2021